Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activated ras. Yet another player in melanoma?

Literature DB >> 8780377

Activated ras. Yet another player in melanoma?

M Herlyn¹, K Satyamoorthy.

Abstract

Entities: Disease

Mesh：

Year: 1996 PMID： 8780377 PMCID： PMC1865164

Source DB: PubMed Journal: Am J Pathol ISSN： 0002-9440 Impact factor: 4.307

× No keyword cloud information.

42 in total

1. Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes.

Authors: D G Lowe; D J Capon; E Delwart; A Y Sakaguchi; S L Naylor; D V Goeddel
Journal: Cell Date: 1987-01-16 Impact factor: 41.582

Review 2. Role of the cyclin-dependent kinase inhibitors in the development of cancer.

Authors: T Hirama; H P Koeffler
Journal: Blood Date: 1995-08-01 Impact factor: 22.113

Review 3. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.

Authors: H Wiseman; B Halliwell
Journal: Biochem J Date: 1996-01-01 Impact factor: 3.857

4. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

Authors: C J Quaife; C A Pinkert; D M Ornitz; R D Palmiter; R L Brinster
Journal: Cell Date: 1987-03-27 Impact factor: 41.582

5. Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice.

Authors: A C Andres; C A Schönenberger; B Groner; L Hennighausen; M LeMeur; P Gerlinger
Journal: Proc Natl Acad Sci U S A Date: 1987-03 Impact factor: 11.205

6. Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter.

Authors: M B Powell; P Hyman; O D Bell; A Balmain; K Brown; D Alberts; G T Bowden
Journal: Mol Carcinog Date: 1995-02 Impact factor: 4.784

7. Carcinogenesis in human skin grafted to SCID mice.

Authors: P W Soballe; K T Montone; K Satyamoorthy; M Nesbit; M Herlyn
Journal: Cancer Res Date: 1996-02-15 Impact factor: 12.701

8. p21ras as a common signaling target of reactive free radicals and cellular redox stress.

Authors: H M Lander; J S Ogiste; K K Teng; A Novogrodsky
Journal: J Biol Chem Date: 1995-09-08 Impact factor: 5.157

9. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.

Authors: D S Gerhard; N C Dracopoli; S J Bale; A N Houghton; P Watkins; C E Payne; M H Greene; D E Housman
Journal: Nature Date: 1987 Jan 1-7 Impact factor: 49.962

10. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma.

Authors: A Platz; U Ringborg; E Grafström; A Höög; B Lagerlöf
Journal: Melanoma Res Date: 1995-04 Impact factor: 3.599

9 in total

Activated ras. Yet another player in melanoma?

1. Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes.

Review 2. Role of the cyclin-dependent kinase inhibitors in the development of cancer.

Review 3. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.

4. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

5. Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice.

6. Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter.

7. Carcinogenesis in human skin grafted to SCID mice.

8. p21ras as a common signaling target of reactive free radicals and cellular redox stress.

9. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.

10. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma.

1. Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.

2. Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth.

3. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

Review 4. Role of nuclear factor-kappa B in melanoma.

5. Role of epidermal growth factor receptor signaling in RAS-driven melanoma.

6. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model.

7. Pigmented uveal tumours in a transgenic mouse model.

8. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.

9. Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation.